About
CAR T
Business development
News & publications
More
Our patented novel CAR T-cell construct is currently in clinical trial in NZ.
Partner with us in developing new cancer therapies.
See our CAR T-cell therapy development pipeline.
See media coverage and relevant publications about our work.